Home/Nanoligent/Dr. M. Rodríguez
DM

Dr. M. Rodríguez

Co-Founder & Entrepreneur

Nanoligent

Therapeutic Areas

Nanoligent Pipeline

DrugIndicationPhase
CXCR4-Targeted TherapyOncology (Tumor Growth & Metastasis)Preclinical